Schizophrenia and Disorders with Psychotic Features  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Schizophrenia and Disorders with Psychotic Features
NCT01987050: Intranasal Oxytocin in Schizophrenia Patients

 
3
71
US
Intranasal oxytocin
University of California, Irvine, National Institute of Mental Health (NIMH), University of California, San Diego
Schizophrenia
09/14
 

Download Options